Wegovy (semaglutide) injection - first approved drug for chronic weight management since 2014
Wegovy (semaglutide) injection (2.4 mg once weekly) has been approved by the…
Lumakras (sotorasib), first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C
The FDA has approved Lumakras (sotorasib) as the first treatment for adult…
Farxiga (dapagliflozin) Approved for the treatment of Chronic Kidney Disease
The FDA has approved Farxiga (dapagliflozin) oral tablets to reduce the risk of…
Enspryng (satralizumab), new treatment for rare autoimmune disease of nerve cells
EMA has recommended granting a marketing authorisation in the European Union…
Novartis receives EU approval for Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for adult patients with relapsing multiple sclerosis
The European Commission has approved Kesimpta® (ofatumumab) for the treatment…
Abecma (idecabtagene vicleucel), First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel),…
ARCALYST (rilonacept) is the first FDA-approved therapy for recurrent pericarditis
The FDA has approved ARCALYST ® (rilonacept), a weekly,…
Evrysdi (Risdiplam), First oral treatment for spinal muscular atrophy (SMA)
EMA has recommended granting a marketing authorisation in the European Union…
Cosela (trilaciclib), first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression
The FDA has approved Cosela (trilaciclib) as the first therapy in its class to…
Breyanzi (lisocabtagene maraleucel), new Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
The U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene…